Lecia Sequist
Overview
Explore the profile of Lecia Sequist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
906
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pirl W, Traeger L, Greer J, Bemis H, Gallagher E, Lennes I, et al.
Oncologist
. 2011 Aug;
16(9):1299-306.
PMID: 21807767
Introduction: Depression appears to be associated with worse survival from cancer, but underlying mechanisms for this association are unknown. In the present study, we explored the degree to which tumor...
12.
Turke A, Zejnullahu K, Wu Y, Song Y, Dias-Santagata D, Lifshits E, et al.
Cancer Cell
. 2010 Feb;
17(1):77-88.
PMID: 20129249
MET amplification activates ERBB3/PI3K/AKT signaling in EGFR mutant lung cancers and causes resistance to EGFR kinase inhibitors. We demonstrate that MET activation by its ligand, HGF, also induces drug resistance,...
13.
West H, Lilenbaum R, Harpole D, Wozniak A, Sequist L
J Thorac Oncol
. 2009 Aug;
4(9 Suppl 2):S1029-39.
PMID: 19704347
Even with the introduction of targeted agents and the establishment of multiple lines of therapy, the median survival for patients with advanced non-small cell lung cancer (NSCLC) does not considerably...
14.
Pirl W, Solis J, Greer J, Sequist L, Temel J, Lynch T
J Clin Oncol
. 2009 Jul;
27(23):e49-50.
PMID: 19597022
No abstract available.
15.
Bradbury P, Heist R, Kulke M, Zhou W, Marshall A, Miller D, et al.
Cancer Epidemiol Biomarkers Prev
. 2008 Jan;
17(1):204-11.
PMID: 18199725
Purpose: Case-control and observational studies are popular choices for evaluating molecular prognostic/pharmacogenetic outcomes, but data quality is rarely tested. Using clinical trial and epidemiologic methods, we assessed the quality of...